Mechanisms of relaxation of rat aorta in response to progesterone and synthetic progestins

Maturitas

Volumn 28, Issue 2, 1997, Pages 181-191

  Glusa, E ^a   Graser T ^b   Wagner, S ^a   Oettel, M ^b  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b BAYER PHARMA AG   (Germany)

Author keywords

17 estradiol; Calcium antagonism; Chlormadinone acetate; Dienogest; Endothelium; Norethisterone acetate; Progesterone; Progestins; Rat aorta; Vascular relaxation

Indexed keywords

CHLORMADINONE ACETATE; DIENOGEST; ESTRADIOL; FORSKOLIN; FULVESTRANT; GESTAGEN; NORETHISTERONE ACETATE; PHENYLEPHRINE; PROGESTERONE; VERAPAMIL;

ANIMAL TISSUE; AORTA; ARTICLE; CALCIUM ANTAGONISM; CONTROLLED STUDY; ENDOTHELIUM; MALE; NONHUMAN; RAT; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ANIMALS; AORTA, THORACIC; CHLORMADINONE ACETATE; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTRADIOL ANTAGONISTS; ESTROGEN ANTAGONISTS; HORMONE ANTAGONISTS; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; NANDROLONE; NORETHINDRONE; PHENYLEPHRINE; PROGESTERONE; PROGESTERONE CONGENERS; RATS; RATS, WISTAR; TIME FACTORS; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VERAPAMIL;

ANIMALIA; NETA;

EID: 0344269335     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(97)00057-1     Document Type: Article

References (46)

1. Gruetta V., Cannon R.O. Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation. 93:1996;1928-1937.
2. Kuhl H. Hormonale Kontrazeption und Substitutionstherapie: Die Bedeutung des Gestagens für kardiovaskuläre Erkrankungen. Geburtshilfe Frauenheilkd. 52:1992;653-662.
3. Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Rosner B., Speizer F.E., Hennekens C.H. Postmenopausal estrogen therapy and cardiovascular disease. New Engl J Med. 325:1991;756-762.
4. Martin K.A., Freeman M.W. Postmenopausal hormone-replacement therapy. New Engl J Med. 328:1993;1115-1117.
5. Stevenson J.C., Crook D., Godsland I.F., Collins P., Whitehead M.I. Hormone replacement therapy and the cardiovascular system: nonlipid effects. Drugs. 47(Suppl. 2):1994;35-41.
6. Samsioe G. Hormone replacement therapy and cardiovascular disease. J Cardiovasc Pharmacol. 28:1996;S51-S57.
7. Riedel M., Oeltermann A., Mügge A., Creutzig A., Rafflenbeul W., Lichtlein P. Vascular responses to 17β-oestradiol in postmenopausal women. Eur J Clin Invest. 25:1995;44-47.
8. Reis S.E., Gloth S.T., Blumenthal R.S.et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation. 89:1994;52-60.
9. Collins P., Rosano G.M.C., Sarrel P.M.et al. 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation. 92:1995;24-30.
10. Sullivan J.M., Shala B.A., Miller L.A., Lerner J.L., McBrayer J.D. Progestin enhances vasoconstrictor responses in postmenopausal women receiving estrogen replacement therapy. J North Am Menopause Soc. 2:1995;193-199.
11. Gerhard M., Ganz P. How do we explain the clinical benefits of estrogen? From bedside to bench. Circulation. 92:1995;5-8.
12. Mügge A., Riedel M., Barton M., Kuhn M., Lichtlen P.R. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res. 27:1993;1939-1942.
13. Williams J.K., Adams M.R., Clarkson T.B. Effects of oestrogen on vascular tone. J Cardiovasc Pharmacol. 28(Suppl. 5):1996;S29-S53.
14. Kim-Schulze S., McGowan K.A., Hubchak S.C., Cid M.C., Martin M.B., Kleinman H.K., Greene G.L., Schnaper H.W. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation. 94:1996;1402-1407.
15. Karas R.H., Patterson B.L., Mendelsohn M.E. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation. 89:1994;1943-1950.
16. Losordo D.W., Kearney M., Kim E.A., Jekanowski J., Isner J.M. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation. 89:1994;1501-1510.
17. Proudler A.J., Ahmed A.I.A., Crook D., Fogelman I., Rymer J.M., Stevenson J.C. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet. 346:1995;89-90.
18. Jiang C., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol. 104:1991;1033-1037.
19. Salas E., Lopez M.G., Villarroya M., Sanchez-Garcia P., DePascual R., Dixon W.R., Garcia A.G. Endothelium-independent relaxation by 17-α-estradiol of pig coronary arteries. Eur J Pharmacol. 258:1994;47-55.
20. Thomas G., Ito K., Zikic E., Bhatti T., Han C., Ramwell P.W. Specific inhibition of the contraction of the rat aorta by estradiol 17β J Pharmacol Exp Ther. 273:1995;1544-1550.
21. Ca channels through a cGMP-dependent mechanism. Circ Res. 77:1995;936-942.
22. Cohen M.L., Susemichel A.D. Effect of 17β-estradiol and the nonsteroidal benzothiophene, LY 117018 on in vitro rat aortic responses to norepinephrine, serotonin, U 46619 and BAYK 8644. Drug Develop Res. 37:1996;97-104.
23. Williams S.P., Shackelford D.P., Iams S.G., Mustafa S.J. Endothelium-dependent relaxation in estrogen-treatment of spontaneously hypertensive rats. Eur J Pharmacol. 145:1988;205-207.
24. McNeill A.M., Duckles S.P., Krause D.N. Relaxant effects of 17β-estradiol in the rat tail artery are greater in females than males. Eur J Pharmacol. 308:1996;305-309.
25. Burenvan G.A., Yang D.S., Clark K.E. Estrogen-induced uterine vasodilation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol. 167:1992;828-833.
26. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA. 91:1994;5212-5216.
27. Chang W.C., Nakao J., Orimo H., Murota S.I. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochem Biophys Acta. 619:1980;107-118.
28. Akishita M., Ouchi Y., Miyoshi H.et al. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis. 125:1996;27-38.
29. Kim Y.D., Chen B., Beauregard J., Kouretas P., Thomas G., Farhat M.Y., Myers A.K., Lees D.E. 17β-Estradiol prevents dysfunction of canine coronary endothelium and myocardium and reperfusion arrhythmias after brief ischemia/reperfusion. Circulation. 94:1996;2901-2908.
30. Mück A.O., Seeger H., Korte K., Lippert T.H. Effect of estradiol on calcium influx in human umbilical cord endothelial cells. Med Sci Res. 22:1994;19.
31. 2 in porcine coronary artery. Circulation. 91:1995;2619-2626.
32. Ogata R., Inoue Y., Nakano H., Ito Y., Kitamura K. Oestradiol-induced relaxation of rabbit basilar artery by inhibition of voltage-dependent Ca channels through GTP-binding protein. Br J Pharmacol. 117:1996;351-359.
33. Chen S.J., Li H., Durand J., Oparil S., Chen Y.F. Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation. 93:1996;577-584.
34. Hanke H., Hanke S., Finking G., Muhic-Lohrer A., Mück A.O., Schmahl F.W., Haasis R., Hombach V. Different effects of estrogen and progesterone on experimental atherosclerosis in female versus male rabbits. Quantification of cellular proliferation by bromdesoxyuridine. Circulation. 94:1996;175-181.
35. Levine R.L., Chen S.J., Durand J., Chen Y.F., Oparil S. Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation. 94:1996;2221-2227.
36. Suzuki A., Mizuno K., Ino Y., Okada M., Kikkawa F., Mizutani S., Tomoda Y. Effects of 17β-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res. 32:1996;516-523.
37. Ingegno M.D., Money S.R., Thelmo W., Greene G.L., Davidian M., Jaffe B.M., Pertschuk L.P. Progesterone receptors in the human heart and large vessels. Lab Invest. 59:1988;353-356.
38. Miller V.M., Vanhoutte P.M. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol. 261:1991;R1022-R1027.
39. Jiang C., Sarrel P.M., Lindsay D.C., Poole-Wilson P.A., Collins P. Progesterone induces endothelium-independent relaxation of rabbit coronary artery in vitro. Eur J Pharmacol. 211:1992;163-167.
40. Mukerji M., Leathard H., Huddart H. Suppression of vasocontractility in rat aorta and portal vein caused by progesterone and pregnanediol. Br J Pharmacol. 116:1995;196P.
41. Bergqvist A., Bergqvist B., Ferno M. Estrogen and progesterone receptors in vessel walls: biochemical and immunological assays. Acta Obstet Gynecol Scand. 72:1993;10-16.
42. Ebeigbe A.B., Müller-Schweinitzer E., Vogel A. Effects of calcium channel blockade in canine saphenous veins after storage at -190°C. Br J Pharmacol. 94:1988;381-388.
43. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193:1951;265-275.
44. Farhat M.Y., Abi-Younes S., Dingaan B., Vargas R., Ramwell P.W. Estradiol increases cyclic adenosine monophosphate in rat pulmonary vascular smooth muscle cells by a nongenomic mechanism. J Pharmacol Exp Ther. 276:1996;652-657.
45. Williams J.K., Honore E.K., Washburn S.A., Clarkson T.B. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J Am Coll Cardiol. 24:1994;1757-1761.
46. Bell D.R., Rensberger H.J., Koritnik D.R., Koshy A. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol. 268:1995;H377-H383.